So we stay at an impasse. People today will proceed to consider drugs—blindly, In most cases—and many will subsequently operate the potential risk of overdose and Loss of life. But if the authorities gained’t offer data and tools for damage minimisation, we will.MAPS will not be supporting off-label use for MDMA therapy at this moment. At thi